Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.

Allan, D S; Keeney, M; Howson-Jan, K; Popma, J; Weir, K; Bhatia, M; Sutherland, D R; Chin-Yee, I H

Allan, D S; Keeney, M; Howson-Jan, K; Popma, J; Weir, K; Bhatia, M; Sutherland, D R; Chin-Yee, I H.

Affiliation

Allan DS; Division of Hematology, University of Western Ontario, London, Ontario, Canada.

Bone Marrow Transplant ; 29(12): 967-72, 2002 Jun.

Article in En | MEDLINE | ID: mdl-12098064

Subject(s)

Antigens, CD34/analysis; Graft Survival; Hematopoietic Stem Cell Transplantation/standards; Adolescent; Adult; Aged; Cell Count; Cell Survival; Cryopreservation/standards; Hematopoietic Stem Cell Transplantation/methods; Hematopoietic Stem Cells/cytology; Hematopoietic Stem Cells/immunology; Humans; Kinetics; Middle Aged; Neoplasms/therapy; Peripheral Blood Stem Cell Transplantation/methods; Peripheral Blood Stem Cell Transplantation/standards; Prognosis; Prospective Studies; Specimen Handling; Transplantation, Autologous/methods; Transplantation, Autologous/standards

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Antigens, CD34 / Graft Survival Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Year: 2002 Type: Article

Search on Google

XML

PubMed Links